Precision oncology using ex vivo technology: a step towards individualised cancer care?

Despite advances in cancer genomics and the increased use of genomic medicine, metastatic cancer is still mostly an incurable and fatal disease. With diminishing returns from traditional drug discovery strategies, and high clinical failure rates, more emphasis is being placed on alternative drug dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Sophie T., Wells, Greg, Conroy, Samantha, Gagg, Hannah, Allen, Richard, Rominiyi, Ola, Helleday, Thomas, Hullock, Katie, Pennington, Catherine E. W., Rantala, Juha, Collis, Spencer J., Danson, Sarah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884776/
https://www.ncbi.nlm.nih.gov/pubmed/36184897
http://dx.doi.org/10.1017/erm.2022.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884776/
https://www.ncbi.nlm.nih.gov/pubmed/36184897
http://dx.doi.org/10.1017/erm.2022.32

Ejemplares similares